# Assessment of the Clinical, Cellular and Molecular Effects of Royalactin-Royal Jelly on the Healing of Wagner Grad II Diabetic Foot Ulcers.

> **NCT07509268** · PHASE2 · COMPLETED · sponsor: **Universidad Autonoma de Nuevo Leon** · enrollment: 10 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Royalactina
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07509268
- **Lead sponsor:** Universidad Autonoma de Nuevo Leon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-09
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07509268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07509268, "Assessment of the Clinical, Cellular and Molecular Effects of Royalactin-Royal Jelly on the Healing of Wagner Grad II Diabetic Foot Ulcers.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07509268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*